Themis Medicare Limited (THEMISMED) - Cash Flow Conversion Efficiency

Latest as of September 2025: -0.004x

Based on the latest financial reports, Themis Medicare Limited (THEMISMED) has a cash flow conversion efficiency ratio of -0.004x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rs-14.84 Million ≈ $-160.49K USD) by net assets (Rs3.80 Billion ≈ $41.10 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see THEMISMED stock market capitalisation for the company's overall valuation and market capitalisation.

Themis Medicare Limited - Cash Flow Conversion Efficiency Trend (2006–2025)

This chart illustrates how Themis Medicare Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Themis Medicare Limited Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Themis Medicare Limited ranked by their cash flow conversion efficiency. Explore cash flow quality index of Themis Medicare Limited to measure how well operating cash flow supports reported net income.

Company Cash Flow Conversion Efficiency
Silk Logistics Holdings Ltd
AU:SLH
0.381x
Trio-Tech International
NYSE MKT:TRT
0.004x
Stomil Sanok SA
WAR:SNK
0.014x
VivoPower PLC
NASDAQ:VIVO
N/A
King Polytechnic Engineering Co Ltd
TWO:6122
0.110x
Indo Kordsa Tbk
JK:BRAM
0.081x
WTK Holdings Bhd
KLSE:4243
0.074x
HB Technology CO.LTD
KQ:078150
0.041x

Annual Cash Flow Conversion Efficiency for Themis Medicare Limited (2006–2025)

The table below shows the annual cash flow conversion efficiency of Themis Medicare Limited from 2006 to 2025. View Themis Medicare Limited (THEMISMED) stock price for real-time trading data and today's change.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-03-31 Rs4.03 Billion
≈ $43.54 Million
Rs347.10 Million
≈ $3.75 Million
0.086x +47.37%
2024-03-31 Rs3.78 Billion
≈ $40.84 Million
Rs220.94 Million
≈ $2.39 Million
0.059x +23.40%
2023-03-31 Rs3.39 Billion
≈ $36.71 Million
Rs160.93 Million
≈ $1.74 Million
0.047x -60.37%
2022-03-31 Rs2.87 Billion
≈ $31.09 Million
Rs343.94 Million
≈ $3.72 Million
0.120x -54.12%
2021-03-31 Rs2.19 Billion
≈ $23.63 Million
Rs569.75 Million
≈ $6.16 Million
0.261x +14440.88%
2020-03-31 Rs1.83 Billion
≈ $19.79 Million
Rs3.28 Million
≈ $35.49K
0.002x -97.41%
2019-03-31 Rs1.58 Billion
≈ $17.09 Million
Rs109.23 Million
≈ $1.18 Million
0.069x +48.70%
2018-03-31 Rs1.69 Billion
≈ $18.26 Million
Rs78.47 Million
≈ $848.62K
0.046x +152.43%
2017-03-31 Rs1.20 Billion
≈ $13.03 Million
Rs-106.78 Million
≈ $-1.15 Million
-0.089x -128.86%
2016-03-31 Rs788.89 Million
≈ $8.53 Million
Rs242.32 Million
≈ $2.62 Million
0.307x +0.33%
2015-03-31 Rs589.08 Million
≈ $6.37 Million
Rs180.34 Million
≈ $1.95 Million
0.306x +188.73%
2014-03-31 Rs561.85 Million
≈ $6.08 Million
Rs59.57 Million
≈ $644.27K
0.106x +25.17%
2013-03-31 Rs537.17 Million
≈ $5.81 Million
Rs45.51 Million
≈ $492.12K
0.085x +132.21%
2012-03-31 Rs580.79 Million
≈ $6.28 Million
Rs-152.73 Million
≈ $-1.65 Million
-0.263x -639.73%
2011-03-31 Rs910.26 Million
≈ $9.84 Million
Rs44.35 Million
≈ $479.64K
0.049x +16.28%
2010-03-31 Rs833.43 Million
≈ $9.01 Million
Rs34.92 Million
≈ $377.67K
0.042x +145.22%
2009-03-31 Rs918.65 Million
≈ $9.93 Million
Rs-85.13 Million
≈ $-920.63K
-0.093x -9.87%
2008-03-31 Rs845.93 Million
≈ $9.15 Million
Rs-71.35 Million
≈ $-771.58K
-0.084x -184.24%
2007-03-31 Rs691.60 Million
≈ $7.48 Million
Rs69.24 Million
≈ $748.82K
0.100x +155.05%
2006-03-31 Rs605.21 Million
≈ $6.55 Million
Rs23.76 Million
≈ $256.92K
0.039x --

About Themis Medicare Limited

NSE:THEMISMED India Drug Manufacturers - Specialty & Generic
Market Cap
$123.48 Million
Rs11.42 Billion INR
Market Cap Rank
#18491 Global
#991 in India
Share Price
Rs123.97
Change (1 day)
+3.44%
52-Week Range
Rs66.07 - Rs142.46
All Time High
Rs300.15
About

Themis Medicare Limited, together with its subsidiaries, manufactures and sells pharmaceutical products in India and internationally. It offers active pharmaceutical ingredients (APIs) and formulations used in various therapeutic areas, including anti-tuberculosis, analgesic and anti-inflammatory, analgesic and antispasmodic, analgesics, anesthesia, antacid-antiflatulent, anti-fungal, antibiotic,… Read more